Filing Details
- Accession Number:
- 0000899243-18-011028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-01 17:14:10
- Reporting Period:
- 2018-04-27
- Accepted Time:
- 2018-05-01 17:14:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1610664 | Cesare Orlandi | C/O Lantheus Holdings, Inc. 331 Treble Cove Road North Billerica MA 01862 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-04-27 | 6,901 | $18.00 | 97,216 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-27 | 1,300 | $18.03 | 95,916 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-30 | 600 | $18.00 | 95,316 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2018.
Billionaire Hedge Funds
